SCOPUS 정보 검색 플랫폼

Journal of Magnetic Resonance Imaging

Volumn 25, Issue 5, 2007, Pages 879-880

On the potential causal relationship between gadolinium-containing MRI agents and nephrogenic systemic fibrosis

(1) Partain, C Leon a

a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT;

CHRONIC KIDNEY FAILURE; CONTRAST ENHANCEMENT; DRUG SAFETY; EDITORIAL; FIBROSIS; HEPATORENAL SYNDROME; HUMAN; NEPHROGENIC SYSTEMIC FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT;

CONGRESSES; CONTRAST MEDIA; FIBROSIS; GADOLINIUM; HUMANS; KIDNEY; MAGNETIC RESONANCE IMAGING; PERIODICALS; PRACTICE GUIDELINES; SKIN DISEASES;

EID: 34247844407 PISSN: 10531807 EISSN: 15222586 Source Type: Journal
DOI: 10.1002/jmri.20982 Document Type: Editorial

Times cited : (4)

References (8)

1
- 33846541879
- Gadodiamide-associated nephrogenic systemic fibrosis: Why radiologists should be concerned
- Broome DR, Girguis MS, Baron PW, Cottrell AC, Kjellin I, Kirk GA. Gadodiamide-associated nephrogenic systemic fibrosis: Why radiologists should be concerned. AJR Am J Roentgenol 2007;188:586-592.
- (2007) AJR Am J Roentgenol , vol.188 , pp. 586-592
- Broome, D.R.¹ Girguis, M.S.² Baron, P.W.³ Cottrell, A.C.⁴ Kjellin, I.⁵ Kirk, G.A.⁶

2
- 34247889994
- Safety update on the possible causal relationship between gadolinium-containing MRI-agents and nephrogenic systemic fibrosis
- Pedersen M. Safety update on the possible causal relationship between gadolinium-containing MRI-agents and nephrogenic systemic fibrosis. J Magn Reson Imaging 2007;25:881-883.
- (2007) J Magn Reson Imaging , vol.25 , pp. 881-883
- Pedersen, M.¹

3
- 33846195472
- 3D Contrast-enhanced MR angiography
- Zhang H, Maki JH, Prince MR. 3D Contrast-enhanced MR angiography. J Magn Reson Imaging 2007;25:13-25.
- (2007) J Magn Reson Imaging , vol.25 , pp. 13-25
- Zhang, H.¹ Maki, J.H.² Prince, M.R.³

4
- 35248856965
- Safety risks with gadolinium-based contrast agents
- in press
- Marzella L, Blank M, Gelperin K, Rosemary J. Safety risks with gadolinium-based contrast agents. J Magn Reson Imaging 2007 (in press).
- (2007) J Magn Reson Imaging
- Marzella, L.¹ Blank, M.² Gelperin, K.³ Rosemary, J.⁴

5
- 34247885091
- USDA, Public Health Advisory, June 3, Updated Dec. 27, 2006. Available at, Last accessed March 19
- USDA, Public Health Advisory. Update on MRI Contrast Agents Containing Gadolinium and Nephrogenic Fibrosis Dermopathy. June 3, 2000. Updated Dec. 27, 2006. Available at http://www.fda.gov/cder/drug/advisory/gadolinium_agents.htm. Last accessed March 19, 2007.
- (2000) Update on MRI Contrast Agents Containing Gadolinium and Nephrogenic Fibrosis Dermopathy

6
- 34247881894
- MR contrast agents: Physical and pharmacologic basics
- Lin SP, Brown JJ. MR contrast agents: Physical and pharmacologic basics. J Magn Reson Imaging 2007;25:884-899.
- (2007) J Magn Reson Imaging , vol.25 , pp. 884-899
- Lin, S.P.¹ Brown, J.J.²

7
- 34247867166
- United States Department of Health and Human Services, Center for Drug Evaluation and Research. Questions and Answers on Gadolinium-Containing Contrast Agents. June 8, Updated August 2, 2006. Available at, Last accessed March 19
- United States Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research. Questions and Answers on Gadolinium-Containing Contrast Agents. June 8, 2006. Updated August 2, 2006. Available at http://www.fda.gov/cder/drug/infopage/gcca/qa_20061222.htm. Last accessed March 19, 2007.
- (2006)

8
- 34249738194
- ACR guidance document for safe MR practices: 2007
- DOI: 10.2214/AJR.06.1616
- Kanal E, Barkovich AJ, Bell C, et al. ACR guidance document for safe MR practices: 2007. AJR Am J Roentgenol 2007; 188: DOI: 10.2214/AJR.06.1616.
- (2007) AJR Am J Roentgenol , pp. 188
- Kanal, E.¹ Barkovich, A.J.² Bell, C.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.